0:00
53:43
Role of Genetic Testing in Advanced M1 CRPC & M1 CPRC Post-docetaxel, Neuroendocrine Cancer and End of Life Care
Presented by Leonard Gomella, MD and Joshua Lang, MD
https://auau.auanet.org/node/34071
Acknowledgements
Support provided by independent educational grants from:
Amgen
Astellas
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Exact Sciences Corporation
Merck
Pfizer, Inc.
Sanofi Genzyme
More episodes from "AUAUniversity"
Don't miss an episode of “AUAUniversity” and subscribe to it in the GetPodcast app.